OWC Pharmaceutical appoints chief scientific officer
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Insight Weekly: Renewables lead capacity additions; bank mergers of equals up; nickel IPOs surge
Insight Weekly: Utilities face headwinds; S&P 500 dividend hikes likely; dollar poised for rally
OWC Pharmaceutical Research Corp. appointed Oron Zeevi as chief scientific officer.
Previously, Zeevi served as chief scientific officer at NeuroDerm Ltd., which was bought by Mitsubishi Tanabe Pharma Corp. for $1.1 billion in 2017.
